Accounting information is crucial for business valuations. One of the hot topics in valuation theory is how to value Research and Development (R&D) intensive businesses. I want you to discuss: Why is R&D crucial for stock valuation? What are the potential disadvantages of classical models, especially the Abnormal Earnings Approach, in terms of valuing stocks of R&D-intensive businesses